Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 9,652 shares at $14.62 ($141K) on 2020-12-16, disclosed to the SEC on 2020-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.49 | 42 | $609 | 0.4% |
| 2 | $14.62 | 4,805 | $70K | 49.8% |
| 3 | $14.62 | 4,805 | $70K | 49.8% |
| Total | $14.62 avg | 9,652 | $141K | 100% |
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |